Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients
<p>Abstract</p> <p>Background</p> <p>Survivin is an inhibitor of apoptosis and a regulator of mitotic progression. TP53 protein is a negative transcriptional regulator of survivin. The aim of our study was to evaluate the clinical significance of survivin expression in...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-11-01
|
Series: | Journal of Ovarian Research |
Subjects: | |
Online Access: | http://www.ovarianresearch.com/content/4/1/20 |